A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

P. Bossi, R. Miceli, L.D. Locati, D. Ferrari, S. Vecchio, G. Moretti, N. Denaro, F. Caponigro, M. Airoldi, C. Moro, E. Vaccher, A. Sponghini, A. Caldara, G. Rinaldi, F. Ferrau, F. Nolè, S. Lo Vullo, F. Tettamanzi, L. Hollander, L. Licitra

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)2820-2826
Number of pages7
JournalAnnals of Oncology
Issue number11
Publication statusPublished - 2017

Cite this